Filtros de búsqueda

Lista de obras de Fabrice André

19q13-ERCC1 gene copy number increase in non--small-cell lung cancer

artículo científico publicado en 2013

3rd ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3).

artículo científico publicado en 2017

3rd ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3).

artículo científico publicado en 2017

3rd ESO-ESMO international consensus guidelines for Advanced Breast Cancer (ABC 3).

artículo científico publicado en 2016

4th ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4)†

artículo científico publicado en 2018

A Phase Ib Open-Label Multicenter Study of AZD4547 in Patients with Advanced Squamous Cell Lung Cancers

artículo científico publicado en 2017

A Systematic Evaluation of Blood Serum and Plasma Pre-Analytics for Metabolomics Cohort Studies

artículo científico publicado en 2016

A TLR3 ligand reestablishes chemotherapeutic responses in the context of FPR1 deficiency

artículo científico publicado en 2020

A direct comparison of CellSearch and ISET for circulating tumour-cell detection in patients with metastatic carcinomas

artículo científico publicado en 2011

A framework to rank genomic alterations as targets for cancer precision medicine: the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT)

artículo científico publicado en 2018

A gene signature to predict high tumor-infiltrating lymphocytes after neoadjuvant chemotherapy and outcome in patients with triple-negative breast cancer

artículo científico publicado en 2017

A high-throughput screen identifies PARP1/2 inhibitors as a potential therapy for ERCC1-deficient non-small cell lung cancer

artículo científico publicado en 2013

A network-based, integrative study to identify core biological pathways that drive breast cancer clinical subtypes

artículo científico publicado en 2012

A nomogram to predict for malignant diagnosis of BI-RADS Category 4 breast lesions

artículo científico publicado en 2010

A phase 2 study of everolimus combined with trastuzumab and paclitaxel in patients with HER2-overexpressing advanced breast cancer that progressed during prior trastuzumab and taxane therapy

artículo científico publicado en 2013

A phase Ib dose allocation study of oral administration of lucitanib given in combination with fulvestrant in patients with estrogen receptor-positive and FGFR1-amplified or non-amplified metastatic breast cancer

scientific article published on 25 January 2019

A retrospective analysis of the outcome of patients who have received two prior chemotherapy regimens including platinum and docetaxel for recurrent non-small-cell lung cancer.

artículo científico publicado en 2003

ATIP3, a novel prognostic marker of breast cancer patient survival, limits cancer cell migration and slows metastatic progression by regulating microtubule dynamics

artículo científico publicado en 2013

Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors

artículo científico publicado en 2009

Adapting the drivers to the road: a new strategy for cancer evolution?

artículo científico publicado en 2015

Added Value of Whole-Exome and Transcriptome Sequencing for Clinical Molecular Screenings of Advanced Cancer Patients With Solid Tumors

scientific article published on 01 July 2018

Adverse event management in patients with advanced cancer receiving oral everolimus: focus on breast cancer

artículo científico publicado en 2014

Alpelisib for PIK3CA-Mutated, Hormone Receptor-Positive Advanced Breast Cancer

scientific article published on 01 May 2019

Amplification of fibroblast growth factor receptor-1 in breast cancer and the effects of brivanib alaninate.

artículo científico publicado en 2009

An epitranscriptomic mechanism underlies selective mRNA translation remodelling in melanoma persister cells

scientific article published on 16 December 2019

Annals of Oncology: factors for making a real impact

artículo científico publicado en 2018

Array CGH and PIK3CA/AKT1 mutations to drive patients to specific targeted agents: a clinical experience in 108 patients with metastatic breast cancer

artículo científico publicado en 2012

Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Ca

artículo científico publicado en 2017

Assessing Tumor-infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method From the International Immunooncology Biomarkers Working Group: Part 1: Assessing the Host Immune Response, TILs in I

artículo científico publicado en 2017

Association between the nuclear to cytoplasmic ratio of p27 and the efficacy of adjuvant polychemotherapy in early breast cancer

artículo científico publicado en 2012

BOLERO-3 results: pharmacological activity or pharmacokinetic effect?--authors' reply

artículo científico publicado en 2014

Benefit of surgery after chemoradiotherapy in stage IIIB (T4 and/or N3) non-small cell lung cancer.

artículo científico publicado en 2001

Bevacizumab: the phoenix of breast oncology?

artículo científico publicado en 2015

Biogenesis of alpha6beta4 integrin in a human colonic adenocarcinoma cell line involvement of calnexin

artículo científico publicado en 1999

Biology-driven phase II trials: what is the optimal model for molecular selection?

artículo científico publicado en 2011

Biomarker discovery, development, and implementation in France: a report from the French National Cancer Institute and cooperative groups.

artículo científico publicado en 2012

Biopsy confirmation of metastatic sites in breast cancer patients: clinical impact and future perspectives

artículo científico publicado en 2014

Brain metastases at the time of presentation of non-small cell lung cancer: a multi-centric AERIO analysis of prognostic factors

artículo científico publicado en 2001

Breast Cancer Index predicts pathological complete response and eligibility for breast conserving surgery in breast cancer patients treated with neoadjuvant chemotherapy.

artículo científico publicado en 2011

Breast cancer in Sub-Saharan African women: review

artículo científico publicado en 2011

Breast-conserving surgery after neoadjuvant anthracycline-based chemotherapy for large breast tumors

artículo científico publicado en 2004

Cancer cell-autonomous contribution of type I interferon signaling to the efficacy of chemotherapy

artículo científico publicado en 2014

Cardiac glycosides exert anticancer effects by inducing immunogenic cell death

artículo científico publicado en 2012

Characteristics, treatment, and outcome of breast cancers diagnosed in BRCA1 and BRCA2 gene mutation carriers in intensive screening programs including magnetic resonance imaging

artículo científico publicado en 2010

Chemotherapy-induced antitumor immunity requires formyl peptide receptor 1.

artículo científico publicado en 2015

Chk1 as a new therapeutic target in triple-negative breast cancer

artículo científico publicado en 2014

Circulating Cell-Free Tumor DNA Analysis of 50 Genes by Next-Generation Sequencing in the Prospective MOSCATO Trial

scientific article published on 12 January 2016

Circulating tumour cells and pathological complete response: independent prognostic factors in inflammatory breast cancer in a pooled analysis of two multicentre phase II trials (BEVERLY-1 and -2) of neoadjuvant chemotherapy combined with bevacizuma

artículo científico publicado en 2017

Cisplatin benefit is predicted by immunohistochemical analysis of DNA repair proteins in squamous cell carcinoma but not adenocarcinoma: theranostic modeling by NSCLC constituent histological subclasses

artículo científico publicado en 2012

Cognitive impairment in breast cancer patients before surgery: results from a CANTO cohort subgroup

artículo científico publicado en 2020

Collagen IV levels are elevated in the serum of patients with primary breast cancer compared to healthy volunteers

artículo científico publicado en 2008

Combination of everolimus with trastuzumab plus paclitaxel as first-line treatment for patients with HER2-positive advanced breast cancer (BOLERO-1): a phase 3, randomised, double-blind, multicentre trial.

artículo científico publicado en 2015

Combinatorial expression of microtubule-associated EB1 and ATIP3 biomarkers improves breast cancer prognosis

artículo científico publicado en 2018

Combined evaluation of LC3B puncta and HMGB1 expression predicts residual risk of relapse after adjuvant chemotherapy in breast cancer

artículo científico publicado en 2015

Combining PI3K and PARP inhibitors for breast and ovarian cancer treatment.

artículo científico publicado en 2017

Comparative genomic hybridisation array and DNA sequencing to direct treatment of metastatic breast cancer: a multicentre, prospective trial (SAFIR01/UNICANCER).

artículo científico publicado en 2014

Consensus on precision medicine for metastatic cancers: a report from the MAP conference.

artículo científico publicado en 2016

Correction: ER+ Breast Cancers Resistant to Prolonged Neoadjuvant Letrozole Exhibit an E2F4 Transcriptional Program Sensitive to CDK4/6 Inhibitors

artículo científico publicado en 2019

Corrigendum to "3rd ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 3)" [Breast 31 (February 2017) 244-259].

artículo científico publicado en 2017

Crizotinib-Resistant ROS1 Mutations Reveal a Predictive Kinase Inhibitor Sensitivity Model for ROS1- and ALK-Rearranged Lung Cancers

artículo científico publicado en 2016

Cross-reactivity between tumor MHC class I-restricted antigens and an enterococcal bacteriophage

artículo científico publicado en 2020

Cyclin E1 Expression and Palbociclib Efficacy in Previously Treated Hormone Receptor–Positive Metastatic Breast Cancer

scientific article published on 26 February 2019

Cyclophosphamide dose intensification may circumvent anthracycline resistance of p53 mutant breast cancers

artículo científico publicado en 2010

DNA arrays as predictors of efficacy of adjuvant/neoadjuvant chemotherapy in breast cancer patients: current data and issues on study design.

artículo científico publicado en 2006

DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy

artículo científico publicado en 2006

DNA repair capacity in circulating lymphocytes and influence on platinum effect in tumor cells

artículo científico publicado en 2012

DNA repair gene patterns as prognostic and predictive factors in molecular breast cancer subtypes.

artículo científico publicado en 2013

De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017

artículo científico publicado en 2017

De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017

artículo científico publicado en 2018

Deciphering root causes of intrinsic BRAF inhibitor resistance in melanoma: ushering in a new genomics case reports feature for Annals of Oncology

artículo científico publicado en 2014

Decision-making from multidisciplinary team meetings to the bedside: factors influencing the recruitment of breast cancer patients into clinical trials

artículo científico publicado en 2014

Defective immunogenic cell death of HMGB1-deficient tumors: compensatory therapy with TLR4 agonists

scientific article published on 28 June 2013

Defining research priorities without biases: what is the optimal process?

scientific article published on 01 February 2017

Dendritic cell derived-exosomes: biology and clinical implementations

artículo científico publicado en 2006

Dendritic cell-derived exosomes as immunotherapies in the fight against cancer

artículo científico publicado en 2014

Dendritic cell-derived exosomes for cancer therapy

artículo científico publicado en 2016

Dendritic cell-derived exosomes promote natural killer cell activation and proliferation: a role for NKG2D ligands and IL-15Ralpha

artículo científico publicado en 2009

Detection of circulating tumor cells harboring a unique ALK rearrangement in ALK-positive non-small-cell lung cancer

artículo científico publicado en 2013

Determination of oestrogen-receptor status and ERBB2 status of breast carcinoma: a gene-expression profiling study

artículo científico publicado en 2007

Developing Anticancer Drugs in Orphan Molecular Entities - A Paradigm under Construction

scientific article published on 01 February 2018

Development of synchronous VHL syndrome tumors reveals contingencies and constraints to tumor evolution

artículo científico publicado en 2014

Discrepancies between primary tumor and metastasis: a literature review on clinically established biomarkers

artículo científico

Disease management patterns for postmenopausal women in Europe with hormone-receptor-positive, human epidermal growth factor receptor-2 negative advanced breast cancer

artículo científico

Distinct tumor protein p53 mutants in breast cancer subgroups

artículo científico publicado en 2012

Does triple-negative phenotype accurately identify basal-like tumour? An immunohistochemical analysis based on 143 'triple-negative' breast cancers

artículo científico publicado en 2007

Dual targeting of HER2-positive cancer with trastuzumab emtansine and pertuzumab: critical role for neuregulin blockade in antitumor response to combination therapy.

artículo científico publicado en 2013

EGFR-independent mechanisms of acquired resistance to AZD9291 in EGFR T790M-positive NSCLC patients.

artículo científico publicado en 2015

ER+ Breast Cancers Resistant to Prolonged Neoadjuvant Letrozole Exhibit an E2F4 Transcriptional Program Sensitive to CDK4/6 Inhibitors

scientific article published on 26 March 2018

ERCC1 function in nuclear excision and interstrand crosslink repair pathways is mediated exclusively by the ERCC1-202 isoform

artículo científico publicado en 2013

ERCC1 influence on the incidence of brain metastases in patients with non-squamous NSCLC treated with adjuvant cisplatin-based chemotherapy

scientific article published on 26 August 2010

ERCC1 isoform expression and DNA repair in non-small-cell lung cancer

artículo científico publicado en 2013

ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2).

artículo científico publicado en 2014

ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)†

artículo científico publicado en 2014

Effect of molecular disease subsets on disease-free survival in randomized adjuvant chemotherapy trials for estrogen receptor-positive breast cancer.

artículo científico publicado en 2008

Effects of acyl-coenzyme A binding protein (ACBP)/diazepam-binding inhibitor (DBI) on body mass index

scientific article published on 09 June 2021

Efficacy of adjuvant chemotherapy according to Prion protein expression in patients with estrogen receptor-negative breast cancer

scientific article published on 14 September 2007

Efficacy of histology-agnostic and molecularly-driven HER2 inhibitors for refractory cancers.

artículo científico publicado en 2018

Epithelial-to-mesenchymal transition and autophagy induction in breast carcinoma promote escape from T-cell-mediated lysis.

artículo científico publicado en 2013

Escherichia coli-specific CXCL13-producing TFH are associated with clinical efficacy of neoadjuvant PD-1 blockade against muscle-invasive bladder cancer

artículo científico publicado en 2022

Estrogen receptor expression and docetaxel efficacy in patients with metastatic breast cancer: a pooled analysis of four randomized trials.

artículo científico publicado en 2010

Estrogen receptor expression and efficacy of docetaxel-containing adjuvant chemotherapy in patients with node-positive breast cancer: results from a pooled analysis.

artículo científico publicado en 2008

Evaluating beauty care provided by the hospital to women suffering from breast cancer: qualitative aspects.

artículo científico publicado en 2009

Evaluation of BGJ398, a Fibroblast Growth Factor Receptor 1-3 Kinase Inhibitor, in Patients With Advanced Solid Tumors Harboring Genetic Alterations in Fibroblast Growth Factor Receptors: Results of a Global Phase I, Dose-Escalation and Dose-Expansi

artículo científico publicado en 2016

Evaluation of changes in serum protein profiles during neoadjuvant chemotherapy in HER2-positive breast cancer using an LC-MALDI-TOF/MS procedure.

artículo científico publicado en 2010

Evaluation of microtubule-associated protein-Tau expression as a prognostic and predictive marker in the NSABP-B 28 randomized clinical trial

artículo científico publicado en 2009

Everolimus for women with trastuzumab-resistant, HER2-positive, advanced breast cancer (BOLERO-3): a randomised, double-blind, placebo-controlled phase 3 trial

artículo científico publicado en 2014

Ewing's family of tumors in adults: multivariate analysis of survival and long-term results of multimodality therapy in 182 patients

artículo científico publicado en 1998

Exonic expression profiling of breast cancer and benign lesions: a retrospective analysis

artículo científico publicado en 2009

Exosome-based immunotherapy

artículo científico publicado en 2004

Exosomes as potent cell-free peptide-based vaccine. I. Dendritic cell-derived exosomes transfer functional MHC class I/peptide complexes to dendritic cells

artículo científico publicado en 2004

Exosomes as potent cell-free peptide-based vaccine. II. Exosomes in CpG adjuvants efficiently prime naive Tc1 lymphocytes leading to tumor rejection

artículo científico

Expression of chemokine receptor CCR6 as a molecular determinant of adrenal metastatic relapse in patients with primary lung cancer

artículo científico publicado en 2010

Expression patterns and predictive value of phosphorylated AKT in early-stage breast cancer

artículo científico publicado en 2007

Fatigue and physical activity in cancer survivors: A cross-sectional population-based study.

artículo científico publicado en 2019

Feasibility and first reports of the MATCH-R repeated biopsy trial at Gustave Roussy

artículo científico publicado en 2020

From the antigen-presenting cell to the antigen-presenting vesicle: the exosomes.

artículo científico publicado en 2002

Funding sources of practice changing trials

artículo científico publicado en 2017

Gene copy number variations in breast cancer of Sub-Saharan African women

scientific article published on 19 September 2012

Gene expression predictors in breast cancer: current status, limitations and perspectives

artículo científico publicado en 2008

Gene modules and response to neoadjuvant chemotherapy in breast cancer subtypes: a pooled analysis.

artículo científico publicado en 2012

Gene pathways associated with prognosis and chemotherapy sensitivity in molecular subtypes of breast cancer.

artículo científico

Genomes in the clinic: the Gustave Roussy Cancer Center experience

artículo científico publicado en 2014

Genomic alterations in breast cancer: level of evidence for actionability according to ESMO Scale for Clinical Actionability of molecular Targets (ESCAT)

artículo científico publicado en 2019

Genomic characterization of metastatic breast cancers

artículo científico publicado en 2019

Genomic index of sensitivity to endocrine therapy for breast cancer.

artículo científico publicado en 2010

HER2 expression and efficacy of preoperative paclitaxel/FAC chemotherapy in breast cancer.

artículo científico

Her2-neu: a target in lung cancer?

artículo científico publicado en 2004

Heterogeneity of breast cancer among patients and implications for patient selection for adjuvant chemotherapy.

artículo científico publicado en 2006

High-Throughput Genomics and Clinical Outcome in Hard-to-Treat Advanced Cancers: Results of the MOSCATO 01 Trial

artículo científico publicado en 2017

Highlights from the 13th St Gallen International Breast Cancer Conference 2013. Access to innovation for patients with breast cancer: how to speed it up?

artículo científico publicado en 2013

Human epidermal receptor family inhibitors in patients with ERBB3 mutated cancers: Entering the back door

artículo científico publicado en 2018

Immune responses during COVID-19 infection

scientific article published on 25 August 2020

Immunodynamics of explanted human tumors for immuno-oncology

artículo científico publicado en 2020

Immunogenic cell death-related biomarkers: Impact on the survival of breast cancer patients after adjuvant chemotherapy

artículo científico publicado en 2015

Immunomodulation via Chemotherapy and Targeted Therapy: A New Paradigm in Breast Cancer Therapy?

artículo científico publicado en 2012

Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer

scientific article published on 30 July 2020

Impact of bioinformatic procedures in the development and translation of high-throughput molecular classifiers in oncology.

artículo científico publicado en 2013

Impact of centralization on aCGH-based genomic profiles for precision medicine in oncology

artículo científico publicado en 2014

Implication of tumor microenvironment in the resistance to chemotherapy in breast cancer patients ⬇️

artículo científico publicado el 1 de noviembre de 2010

Implications of personalized medicine--perspective from a cancer center

artículo científico publicado en 2011

Improving the Performance of Somatic Mutation Identification by Recovering Circulating Tumor DNA Mutations

artículo científico publicado en 2016

Inclusion of taxanes, particularly weekly paclitaxel, in preoperative chemotherapy improves pathologic complete response rate in estrogen receptor-positive breast cancers

artículo científico publicado en 2007

Integration of host-related signatures with cancer cell-derived predictors for the optimal management of anticancer chemotherapy

artículo científico publicado en 2010

Integrin ligation and PKC activation are required for migration of colon carcinoma cells.

artículo científico publicado en 1998

Intestinal microbiota influences clinical outcome and side effects of early breast cancer treatment

artículo científico publicado en 2021

Issues in clinical research for metastatic breast cancer

artículo científico publicado en 2013

Ki-67: level of evidence and methodological considerations for its role in the clinical management of breast cancer: analytical and critical review

artículo científico publicado en 2011

Ki67 expression and docetaxel efficacy in patients with estrogen receptor-positive breast cancer

artículo científico publicado en 2009

Kinetics of serum HER-2/neu changes in patients with HER-2-positive primary breast cancer after initiation of primary chemotherapy

artículo científico publicado en 2007

Long term HER2+ metastatic breast cancer survivors treated by trastuzumab: Results from the French cohort study LHORA.

artículo científico publicado en 2015

Microtubule-associated protein-tau is a bifunctional predictor of endocrine sensitivity and chemotherapy resistance in estrogen receptor-positive breast cancer

artículo científico publicado en 2007

Mitotic index and benefit of adjuvant anthracycline-based chemotherapy in patients with early breast cancer

artículo científico publicado en 2005

Modulation of Rb phosphorylation and antiproliferative response to palbociclib: the preoperative-palbociclib (POP) randomized clinical trial

artículo científico publicado en 2018

Molecular Alterations and Everolimus Efficacy in Human Epidermal Growth Factor Receptor 2-Overexpressing Metastatic Breast Cancers: Combined Exploratory Biomarker Analysis From BOLERO-1 and BOLERO-3.

artículo científico publicado en 2016

Molecular Characteristics of ERCC1-Negative versus ERCC1-Positive Tumors in Resected NSCLC.

artículo científico publicado en 2011

Molecular anatomy of breast cancer stroma and its prognostic value in estrogen receptor-positive and -negative cancers.

artículo científico publicado en 2010

Molecular biology in breast cancer: should molecular classifiers be assessed by conventional tools or by gene expression arrays?

artículo científico

Molecular characterization of breast cancer with high-resolution oligonucleotide comparative genomic hybridization array.

artículo científico publicado en 2009

Molecular circuits of solid tumors: prognostic and predictive tools for bedside use.

scientific article published on 15 June 2010

Molecular classification of breast cancer: implications for selection of adjuvant chemotherapy.

artículo científico publicado en 2006

Molecular pathways: involvement of immune pathways in the therapeutic response and outcome in breast cancer.

artículo científico publicado en 2012

Molecular subclasses of breast cancer: how do we define them? The IMPAKT 2012 Working Group Statement.

artículo científico publicado en 2012

Multidrug resistance proteins do not predict benefit of adjuvant chemotherapy in patients with completely resected non-small cell lung cancer: International Adjuvant Lung Cancer Trial Biologic Program

artículo científico publicado en 2007

Mutational Profile of Metastatic Breast Cancers: A Retrospective Analysis.

artículo científico publicado en 2016

Natural and therapy-induced immunosurveillance in breast cancer

artículo científico

Natural history, management and pharmacokinetics of everolimus-induced-oral ulcers: insights into compliance issues.

artículo científico publicado en 2011

New strategies to overcome resistance to mammalian target of rapamycin inhibitors in breast cancer.

artículo científico publicado en 2013

News from the San Antonio Breast Cancer Symposium 2018

scientific article published on 13 February 2019

Next-generation sequencing reveals high concordance of recurrent somatic alterations between primary tumor and metastases from patients with non-small-cell lung cancer

artículo científico publicado en 2013

Nuclear localization of the caspase-3-cleaved form of p73 in anoikis

artículo científico publicado en 2015

Opposing effects of toll-like receptor (TLR3) signaling in tumors can be therapeutically uncoupled to optimize the anticancer efficacy of TLR3 ligands

artículo científico publicado en 2010

Optimal strategies for the treatment of metastatic triple-negative breast cancer with currently approved agents

artículo científico publicado en 2012

Outcome in breast molecular subtypes according to nodal status and surgical procedures.

artículo científico publicado en 2013

P53 family: at the crossroads in cancer therapy

artículo científico publicado en 2009

PARP1 impact on DNA repair of platinum adducts: preclinical and clinical read-outs

artículo científico publicado en 2013

Palbociclib Combined with Fulvestrant in Premenopausal Women with Advanced Breast Cancer and Prior Progression on Endocrine Therapy: PALOMA-3 Results

artículo científico publicado en 2017

Palbociclib in Hormone-Receptor-Positive Advanced Breast Cancer

artículo científico publicado en 2015

Patterns of resource utilization and cost for postmenopausal women with hormone-receptor-positive, human epidermal growth factor receptor-2-negative advanced breast cancer in Europe

artículo científico publicado en 2015

Pembrolizumab plus trastuzumab in trastuzumab-resistant, advanced, HER2-positive breast cancer (PANACEA): a single-arm, multicentre, phase 1b-2 trial

scientific article published on 11 February 2019

Peritoneal carcinomatosis in germ-cell tumor: relations with retroperitoneal lymph node dissection

artículo científico publicado en 2000

Persistence of viable tumor cells after radiation and chemotherapy for stage IIIB non-small cell lung cancer: an early marker of treatment failure

artículo científico publicado en 2001

Personalized medicine in oncology: where have we come from and where are we going?

artículo científico publicado en 2013

Pervasive chromosomal instability and karyotype order in tumour evolution

artículo científico publicado en 2020

Phase I Study of Everolimus Plus Weekly Paclitaxel and Trastuzumab in Patients With Metastatic Breast Cancer Pretreated With Trastuzumab ⬇️

artículo científico publicado el 25 de octubre de 2010

Phase I/IIa study evaluating the safety, efficacy, pharmacokinetics, and pharmacodynamics of lucitanib in advanced solid tumors

artículo científico publicado en 2014

Phase II, randomized, placebo-controlled study of dovitinib in combination with fulvestrant in postmenopausal patients with HR+, HER2- breast cancer that had progressed during or after prior endocrine therapy

artículo científico publicado en 2017

Plasma ESR1 Mutations and the Treatment of Estrogen Receptor-Positive Advanced Breast Cancer.

artículo científico

Polyclonal RB1 mutations and acquired resistance to CDK 4/6 inhibitors in patients with metastatic breast cancer.

artículo científico publicado en 2017

Precision medicine for metastatic breast cancer--limitations and solutions.

artículo científico

Precision medicine for metastatic breast cancer.

artículo científico publicado en 2015

Prevalence of elevated serum CA 15-3 at time of metastatic relapse of breast cancer and correlation with hormone receptor status

artículo científico publicado en 2009

Prognostic and predictive value of tumor-infiltrating lymphocytes in two phase III randomized adjuvant breast cancer trials

artículo científico publicado en 2015

Prognostic value of tumor-infiltrating lymphocytes on residual disease after primary chemotherapy for triple-negative breast cancer: a retrospective multicenter study

artículo científico publicado en 2014

Prognostic value of tumor-infiltrating lymphocytes on residual disease after primary chemotherapy for triple-negative breast cancer: a retrospective multicenter study

artículo científico publicado en 2015

Progresses toward precision medicine in RET-altered solid tumors

artículo científico publicado en 2020

Prolonged SARS-CoV-2 RNA virus shedding and lymphopenia are hallmarks of COVID-19 in cancer patients with poor prognosis

artículo científico publicado en 2021

Publisher Correction: Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer

scientific article published on 17 September 2020

Rationale for targeting fibroblast growth factor receptor signaling in breast cancer

artículo científico publicado en 2015

Regulation of RNA polymerase III transcription during transformation of human IMR90 fibroblasts with defined genetic elements.

artículo científico publicado en 2017

Reply to D.C. Sgroi et al, T. Sanft et al, M.S. Copur et al, and M.P. Goetz et al

scientific article published on 01 November 2016

Reproducibility of research and preclinical validation: problems and solutions.

artículo científico publicado en 2013

Residual ductal carcinoma in situ in patients with complete eradication of invasive breast cancer after neoadjuvant chemotherapy does not adversely affect patient outcome

scientific article published on 01 July 2007

Resistance to HER2 inhibitors: is addition better than substitution? Rationale for the hypothetical concept of drug sedimentation

scientific article published on June 2010

Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer

artículo científico publicado en 2008

Retinoic acid receptor alpha amplifications and retinoic acid sensitivity in breast cancers

artículo científico publicado en 2013

Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer.

artículo científico publicado en 2016

Risk factors for brain relapse in patients with metastatic breast cancer

artículo científico publicado en 2004

Somatic Genomic Testing in Patients With Metastatic or Advanced Cancer: ASCO Provisional Clinical Opinion

artículo científico publicado en 2022

Spectrum of breast cancer metastasis in BRCA1 mutation carriers: highly increased incidence of brain metastases

artículo científico publicado en 2005

Statistical controversies in clinical research: statistical significance-too much of a good thing ….

artículo científico publicado en 2016

Strategies to overcome trastuzumab resistance in HER2-overexpressing breast cancers: focus on new data from clinical trials.

artículo científico publicado en 2014

Supervision after breast cancer treatment

artículo científico publicado en 2013

Survival of patients with resected N2 non-small-cell lung cancer: evidence for a subclassification and implications

scientific article published on 01 August 2000

TLR3 as a biomarker for the therapeutic efficacy of double-stranded RNA in breast cancer

artículo científico publicado en 2011

TP53 mutation-correlated genes predict the risk of tumor relapse and identify MPS1 as a potential therapeutic kinase in TP53-mutated breast cancers.

artículo científico publicado en 2014

Targeted therapies for ER+/HER2- metastatic breast cancer

artículo científico publicado en 2015

Targeting FGFR Signaling in Cancer

artículo científico

Targeting FGFR with dovitinib (TKI258): preclinical and clinical data in breast cancer

artículo científico publicado en 2013

Targeting TCTP with Sertraline and Thioridazine in Cancer Treatment

artículo científico publicado en 2017

Targeting the deregulated spliceosome core machinery in cancer cells triggers mTOR blockade and autophagy

artículo científico publicado en 2013

The Role of Next-Generation Sequencing in Enabling Personalized Oncology Therapy.

artículo científico publicado en 2016

The anticancer immune response: indispensable for therapeutic success?

artículo científico publicado en 2008

The challenge of rapid diagnosis in oncology: Diagnostic accuracy and cost analysis of a large-scale one-stop breast clinic

artículo científico publicado en 2016

The challenge to bring personalized cancer medicine from clinical trials into routine clinical practice: the case of the Institut Gustave Roussy ⬇️

artículo científico

The genetic landscape and clonal evolution of breast cancer resistance to palbociclib plus fulvestrant in the PALOMA-3 trial

artículo científico publicado en 2018

The growing teratoma syndrome: results of therapy and long-term follow-up of 33 patients

artículo científico publicado en 2000

The interaction between HMGB1 and TLR4 dictates the outcome of anticancer chemotherapy and radiotherapy

artículo científico publicado en 2007

The potential of exosomes in immunotherapy

artículo científico publicado en 2005

The potential of exosomes in immunotherapy of cancer

artículo científico publicado en 2005

The presence of LC3B puncta and HMGB1 expression in malignant cells correlate with the immune infiltrate in breast cancer

artículo científico publicado en 2016

The ratio of CD8+/FOXP3 T lymphocytes infiltrating breast tissues predicts the relapse of ductal carcinoma in situ

artículo científico publicado en 2016

Towards a global cancer knowledge network: dissecting the current international cancer genomic sequencing landscape

artículo científico publicado en 2017

Translational regulation of the mRNA encoding the ubiquitin peptidase USP1 involved in the DNA damage response as a determinant of Cisplatin resistance

artículo científico publicado en 2016

Treatment of triple-negative metastatic breast cancer: toward individualized targeted treatments or chemosensitization?

artículo científico publicado en 2010

Tumor genotyping for breast cancer: at the front door

artículo científico publicado en 2011

Tumor-Infiltrating Lymphocytes and Prognosis: A Pooled Individual Patient Analysis of Early-Stage Triple-Negative Breast Cancers

artículo científico publicado en 2019

Tumor-infiltrating lymphocytes and response to neoadjuvant chemotherapy with or without carboplatin in human epidermal growth factor receptor 2-positive and triple-negative primary breast cancers

artículo científico publicado en 2014

Tumor-specific circulating angiogenic progenitors in breast and renal cell cancer: What prospects?

artículo científico publicado en 2017

TumorTracer: a method to identify the tissue of origin from the somatic mutations of a tumor specimen

artículo científico publicado en 2015

Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline

artículo científico publicado en 2016

Use of guidelines and heterogeneity of decision making for adjuvant chemotherapy in hormone-receptor positive, HER2-negative, early breast cancer: results of a French national survey

artículo científico publicado en 2014

Utility of prognostic genomic tests in breast cancer practice: The IMPAKT 2012 Working Group Consensus Statement

artículo científico publicado en 2013

Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of thefirst phase I clinical trial

artículo científico publicado en 2005

What can breast cancer molecular sub-classification add to conventional diagnostic tools?

artículo científico publicado en 2007

What to expect from high throughput genomics in metastatic breast cancers?

artículo científico publicado en 2015

Whole exome sequencing for determination of tumor mutation load in liquid biopsy from advanced cancer patients

artículo científico publicado en 2017

Whole exome sequencing of rare aggressive breast cancer histologies.

artículo científico publicado en 2016

[Breast cancer screening: On our way to the future].

artículo científico publicado en 2016

[Erratum to: "Breast cancer screening: On our way to the future" [Bull. Cancer 103 (2016) 753-763]]

artículo científico publicado en 2016

[Her2 a paradigm for targeted therapy].

artículo científico publicado en 2011

[Tumor resistance to HER2 inhibitors: the drug sedimentation concept].

artículo científico publicado en 2012

mTOR inhibitors in advanced breast cancer: ready for prime time?

artículo científico

mTOR inhibitors in the management of hormone receptor-positive breast cancer: the latest evidence and future directions.

artículo científico publicado en 2012

p53 status and efficacy of primary anthracyclines/alkylating agent-based regimen according to breast cancer molecular classes

artículo científico publicado en 2008

rCGH: a comprehensive array-based genomic profile platform for precision medicine

artículo científico publicado en 2015

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda